Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 22, 2024

SELL
$222.59 - $267.94 $5.63 Million - $6.78 Million
-25,305 Reduced 96.04%
1,043 $269,000
Q3 2023

Oct 30, 2023

BUY
$253.3 - $285.89 $2.11 Million - $2.38 Million
8,340 Added 46.31%
26,348 $6.77 Million
Q2 2023

Aug 15, 2023

BUY
$275.25 - $318.06 $1.05 Million - $1.22 Million
3,825 Added 26.97%
18,008 $5.13 Million
Q1 2023

May 11, 2023

BUY
$256.56 - $292.34 $910,274 - $1.04 Million
3,548 Added 33.36%
14,183 $3.94 Million
Q4 2022

Jan 24, 2023

BUY
$252.44 - $306.72 $202,709 - $246,296
803 Added 8.17%
10,635 $2.95 Million
Q3 2022

Oct 20, 2022

SELL
$194.69 - $268.46 $709,255 - $977,999
-3,643 Reduced 27.04%
9,832 $2.63 Million
Q2 2022

Jul 26, 2022

SELL
$187.54 - $223.02 $41,446 - $49,287
-221 Reduced 1.61%
13,475 $2.75 Million
Q1 2022

Apr 26, 2022

SELL
$193.77 - $244.14 $3,487 - $4,394
-18 Reduced 0.13%
13,696 $2.89 Million
Q4 2021

Mar 11, 2022

BUY
$223.92 - $287.77 $902,845 - $1.16 Million
4,032 Added 41.64%
13,714 $3.29 Million
Q3 2021

Oct 15, 2021

BUY
$282.99 - $369.05 $2.74 Million - $3.57 Million
9,682 New
9,682 $2.74 Million
Q4 2020

Jan 13, 2021

SELL
$236.26 - $355.63 $895,425 - $1.35 Million
-3,790 Closed
0 $0
Q3 2020

Oct 15, 2020

BUY
$264.77 - $305.71 $9,002 - $10,394
34 Added 0.91%
3,790 $1.08 Million
Q2 2020

Jul 15, 2020

SELL
$258.66 - $342.55 $633,717 - $839,247
-2,450 Reduced 39.48%
3,756 $1.01 Million
Q1 2020

Apr 17, 2020

BUY
$268.85 - $341.04 $1.48 Million - $1.88 Million
5,511 Added 792.95%
6,206 $1.96 Million
Q4 2019

Jan 15, 2020

BUY
$220.06 - $304.07 $152,941 - $211,328
695 New
695 $206,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.